Newron
Newron is headquartered in Italy, lists 51–200 employees, and has $39.7M in recorded funding across 3 rounds.
- Employees
- 51–200
- Business Model
- B2B
- Website
- newron.com
- Total Funding
- $39.7M
- Last Round
- $39.7M Corporate RoundFeb 2026
- Rounds
- 3
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 3 funding rounds and 3 investors for this company. The full record is or through the API.
About
Newron Pharmaceuticals is a biopharmaceutical company focused on developing novel therapies for patients with CNS diseases and pain. The company approved product Xadago (safinamide) is a Parkinson disease treatment approved in over 20 markets worldwide.
Summary
Newron is a Biotech company based in Italy. It lists 51–200 employees. It has raised $39.7M in total across 3 rounds, most recently a $39.7M Corporate Round in Feb 2026. Investors include Omega Funds, 3i and TVM Capital.
Funding History
Feb 2026
Sign up to see all 3 events
Funding: Venture Round through Corporate Round. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/newron"><img src="https://indexed.vc/api/badge/company/newron" alt="Newron on Indexed.vc" width="260" height="76" /></a>